IFNG and asthma: Other studies using the STIM-ORAI antagonist SKF 96365 reduced key inflammatory cytokines, including IL-4, IL-5, IL-12, IL-13, IFN-γ, and TNF-α, and effectively reversed airway tissue remodeling in ovalbumin-induced asthma models [58].